You are here

  • Home
  • Archive
  • Volume 13, Issue 1
  • Intensive glucose control in type 2 diabetes reduces cardiovascular disease, but not cardiovascular or all-cause mortality, and increases risk of severe hypoglycaemia

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review
Intensive glucose control in type 2 diabetes reduces cardiovascular disease, but not cardiovascular or all-cause mortality, and increases risk of severe hypoglycaemia
  1. Deborah Chyun
  1. Deborah Chyun
    Florence S. Downs Director, Program in Nursing Research and Theory Development, College of Nursing, New York University, 726 Broadway, New York, NY 10003, USA; dc116{at}nyu.edu

https://doi.org/10.1136/ebn1001-1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Kelly TN, Bazzano LA, Fonseca VA, et al. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009;151:394–403.OpenUrlCrossRefPubMedWeb of Science

    Previous studies—the Diabetes Control and Complications Trial1 in type 1 diabetes and the United Kingdom Prospective Diabetes Study2 in type 2 diabetes—have clearly demonstrated the benefits of intensive glucose control for the prevention of the microvascular complications of diabetes (neuropathy, nephropathy and retinopathy). In addition, long-term follow-up of the younger subjects with type 1 diabetes who were enrolled in the Diabetes Control and Complications Trial demonstrated that those in the intensive arm had a reduced risk of developing cardiovascular disease (CVD), long after the initial phase of the study.3 However, the effects …

    View Full Text

    Footnotes

    • Competing interests None.